Cardinal Health (CAH) closed at $133.69 in the latest trading session, marking a +1.92% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 2.51%. Elsewhere, the ...

Cardinal Health Inc. closed 4.16% short of its 52-week high of $139.50, which the company reached on April 3rd.

Valued at a market cap of $31.7 billion, Dublin, Ohio-based Cardinal Health, Inc. (CAH) is one of the largest U.S.

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

We recently published a list of Jim Cramer’s List of 16 Stocks to Buy Right Now. In this article, we are going to take a look ...

Yes, I do think we need non-glucocorticoid forms of therapy to treat 21-hydroxylase deficiency congenital adrenal hyperplasia.The most common form of congenital adrenal hyperplasia (CAH) is a ...

Medical leaders are worried about potential cuts to Critical Access Hospitals (CAH), a special designation given by the ...

FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that its Board of Directors has approved a 1 for 10 reverse stock split of the Company’s Class A common stock, ...

To get a sense of who is truly in control of Cardinal Health, Inc. (NYSE:CAH), it is important to understand the ownership ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The ...